(Reuters) – Gilead Sciences Inc said on Monday it will provide support to new local manufacturing facilities in India and donate active pharmaceutical ingredient to scale up production of its COVID-19 drug, remdesivir. (https://refini.tv/2QqfmCn)
(Reporting by Trisha Roy in Bengaluru; Editing by Arun Koyyur)
